On the other hand, approximately 75% of TP53 mutations in cancer are missense mutations in hot spots, resulting in the expression of mutant p53 with single amino acid substitutions, and such mutant p53 is thought to acquire a novel oncogenic function (5, 6). This evidence concerns the gene TP53 and cancer.